Literature DB >> 2821621

Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor.

R Sapolsky1, C Rivier, G Yamamoto, P Plotsky, W Vale.   

Abstract

There is now evidence that the immune system, during times of infectious challenge, can stimulate the secretion of glucocorticoids, the adrenal steroids that mediate important aspects of the response to stress. Specifically, secretion of interleukin-1 (IL-1), a monocyte lymphokine secreted after infection, appears at least in part responsible for this effect. Glucocorticoids are secreted in response to a neuroendocrine cascade involving, first, the brain, then the pituitary, and finally the adrenal gland. In this report, human IL-1 is shown to activate the adrenocortical axis at the level of the brain, stimulating the release of the controlling hormone corticotropin-releasing factor (CRF) from the hypothalamus. Infusion of IL-1 induced a significant secretion of CRF into the circulation exiting the hypothalamus, whereas immunoneutralization of CRF blocked the stimulatory effect of IL-1 on glucocorticoid secretion. IL-1 appeared to have no acute direct stimulatory effects on the pituitary or adrenal components of this system. Furthermore, IL-1 did not cause a nonspecific release of other hypothalamic hormones. Thus, the lymphokine acts in a specific manner to activate the adrenocortical axis at the level of the brain; this effect appears to be unrelated to the known pyrogenic effects of IL-1 within the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821621     DOI: 10.1126/science.2821621

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  212 in total

1.  Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1.

Authors:  A Ericsson; C Arias; P E Sawchenko
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  Congenitally determined neurodegeneration "Lurcher" induces morphofunctional changes of thymus.

Authors:  P Mandáková; M Virtová; P Síma; M Beranová; J Slípka
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

3.  Commentary: Parallel evolution of Molecular Endocrinology as a journal and a discipline: convergence of interests with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH).

Authors:  Ronald Margolis; Philip Smith
Journal:  Mol Endocrinol       Date:  2010-07-21

Review 4.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

5.  Deletion of the ventral noradrenergic bundle obliterates the early ACTH response after systemic LPS, independently from the plasma IL-1β surge.

Authors:  L Givalois; S Gaillet; M Mekaouche; C Ixart; A F Bristow; P Siaud; A Szafarczyk; F Malaval; I Assenmacher; G Barbanel
Journal:  Endocrine       Date:  1995-07       Impact factor: 3.633

6.  Possible involvement of prostaglandin E in development of ACTH response in rats induced by human recombinant interleukin-1.

Authors:  A Morimoto; N Murakami; T Nakamori; Y Sakata; T Watanabe
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

7.  The effect of adrenalectomy on interleukin-1 release in vitro and in vivo.

Authors:  M Perretti; C Becherucci; G Scapigliati; L Parente
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

Review 8.  Getting nervous about immunity.

Authors:  Keith W Kelley; Robert H McCusker
Journal:  Semin Immunol       Date:  2014-02-18       Impact factor: 11.130

9.  ACTH response induced in capsaicin-desensitized rats by intravenous injection of interleukin-1 or prostaglandin E.

Authors:  T Watanabe; A Morimoto; N Tan; T Makisumi; S G Shimada; T Nakamori; N Murakami
Journal:  J Physiol       Date:  1994-02-15       Impact factor: 5.182

Review 10.  Role of interleukin-1 in stress responses. A putative neurotransmitter.

Authors:  F Shintani; T Nakaki; S Kanba; R Kato; M Asai
Journal:  Mol Neurobiol       Date:  1995-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.